Nicotine patch: Clinical Trials

22 trials of Nicotine patch, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed. 22 Phase 2, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 222Completed 22
Phase 13Completed 3
Phase 33Completed 3

Follow Nicotine patch: new trials by email Literature Review of Nicotine patch trials Research Report on Nicotine patch

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exenatide for Smoking Cessation and Prevention of Weight Gain
Exenatide 2 milligram (mg) Injection, Placebo, Nicotine patch - Smoking Cessation, Weight Gain
Phase 2CompletedThe University of Texas Health Science Center, Houston1402022-12-072026-03-23
Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors in Laos
Nicotine patch, Self-help materials (to support smoking cessation), Smartphone-based automated treatment for smoking cessation - Cigarette Smoking
Phase 2CompletedUniversity of Oklahoma802022-04-202024-08-28
Heart Rate Variability Biofeedback for Smoking Cessation Treatment
Cognitive-Behavioral Smoking Cessation, Heart Rate Variability Biofeedback, Nicotine patch - Tobacco Smoking
Phase 2CompletedRutgers, The State University of New Jersey282021-11-292024-05-01
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
Juul Electronic cigarette, Very Low Nicotine Cigarettes, Active Nicotine Patch - Nicotine Dependence
Phase 2CompletedUniversity of Wisconsin, Madison2092020-09-092023-05-25
Heart Rate Variability Biofeedback for Smoking Cessation
Cognitive-Behavioral Smoking Cessation, Heart Rate Variability Biofeedback (HRVB), Transdermal Nicotine patch - Tobacco Smoking
Phase 2CompletedRutgers, The State University of New Jersey102019-04-242020-08-25
Treating Smokers With Mental Illness
Nicotine patch, Nicotine lozenge, Therapy - Smoking Cessation, Cigarette Smoking
Phase 2CompletedUniversity of Minnesota382019-03-012021-05-25
The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products
Nicotine patch, Placebo patch, E-cigarettes - Nicotine Dependence, Cigarettes
Phase 2CompletedDuke University942018-08-062023-02-08
PRecision Interventions for SMoking in the SCCS
Nicotine patch, Varenicline, Nicotine metabolism - Tobacco Use Cessation
Phase 2 / Phase 3CompletedVanderbilt University Medical Center672018-05-182020-06-01
Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
CQSS2, NicoDerm CQ Patch - Smoking Cessation
Phase 2CompletedChrono Therapeutics, Inc.2202017-08-072017-12-04
Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation
Nicotine Patch, SPECTRUM Nicotine Research Cigarettes (.03 mg), Behavioral Activation - Smoking
Phase 1 / Phase 2CompletedMaggie M Sweitzer, PhD352017-02-012022-06-28
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
lorcaserin, nicotine patch, placebo lorcaserin - Nicotine Dependence
Phase 2CompletedDuke University972016-11-082019-05-07
Exenatide Once Weekly for Smoking Cessation
Exenatide, NRT, Counseling - Smoking Cessation
Phase 1 / Phase 2CompletedThe University of Texas Health Science Center, Houston842016-07-012021-01-28
Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers
Nicotine Patch, Questionnaires, Carbon Monoxide (CO) Test - Tobacco Use Cessation, Cancer Prevention
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center262015-11-022020-03-10
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Nicotine Patch, Moclobemide - Nicotine Dependence
Phase 2CompletedJed E. Rose762013-09-012017-08-23
Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate
Ganaxolone, Nicotine Patch - Smoking Cessation
Phase 2CompletedJed E. Rose362013-06-012014-09-08
Meclizine as a Potential Smoking Cessation Treatment
Meclizine, Nicotine Patch, Placebo - Smoking Cessation
Phase 2CompletedDuke University1462011-08-012014-08-01
Innovative Interventions for Smoking Cessation
Nicotine Patch, VLNC Cigarette, VLNC Cigarette Plus Nicotine Patch - Tobacco Use Disorder
Phase 2CompletedUniversity of Minnesota2352008-10-012019-11-18
Extended Cessation Treatment for Teen Smokers
Extended treatment - Nicotine Dependence
Phase 2 / Phase 3CompletedStanford University1412006-09-012016-05-30
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
Transdermal Nicotine Patch, 21 mg transdermal nicotine, placebo patch - Schizophrenia and Disorders With Psychotic Features, Tobacco Use Disorder
Phase 2CompletedNational Institute on Drug Abuse (NIDA)482002-06-012017-01-12
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
Nicotine Replacement Therapies, Nicotine patch, Folic Acid - Smoking Cessation, Tobacco Use Disorder
Phase 2CompletedNational Institute on Drug Abuse (NIDA)1282002-04-012017-01-10

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Smoking Cessation (12)  ·  Tobacco Use Disorder (9)  ·  Cigarette Smoking (7)  ·  Smoking (4)  ·  Tobacco Use Cessation (3)  ·  Schizophrenia (2)  ·  Tobacco Smoking (2)  ·  Behavior, Addictive (1)  ·  Bipolar Disorder (1)  ·  Depressive Disorder, Major (1)  ·  Glucose Intolerance (1)  ·  Health Education (1)  ·  Mental Disorders (1)  ·  Overweight (1)  ·  Psychotic Disorders (1)

Sponsors

Duke University (3)  ·  National Institute on Drug Abuse (NIDA) (3)  ·  Jed E. Rose (2)  ·  Rutgers, The State University of New Jersey (2)  ·  The University of Texas Health Science Center, Houston (2)  ·  University of Minnesota (2)  ·  Chrono Therapeutics, Inc. (1)  ·  M.D. Anderson Cancer Center (1)  ·  Maggie M Sweitzer, PhD (1)  ·  Stanford University (1)  ·  US Department of Veterans Affairs (1)  ·  University of Oklahoma (1)  ·  University of Wisconsin, Madison (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (21)  ·  Laos (1)

Top investigators

Jed E Rose, Ph.D. (3)  ·  Jed E. Rose, Ph.D. (2)  ·  Luba Yammine, PhD (2)  ·  Allen Wyler, MD (1)  ·  Dorothy Hatsukami, Ph.D. (1)  ·  Dorothy Hatsukami, PhD (1)  ·  Eric C Westman, M.D. (1)  ·  Eric T. Moolchan, M.D. (1)  ·  Harry Lando, PhD (1)  ·  Hilary A Tindle, MD, MPH (1)  ·  Jennifer W. Tidey (1)  ·  Joel D Killen, PhD (1)  ·  Maggie M Sweitzer, PhD (1)  ·  Marcel A. de Dios, PHD (1)  ·  Maureen Sanderson, PhD, RD, MPH (1)

Results publications

PMID 23460656, PMID 23603206, PMID 25192771, PMID 30633744, PMID 31589323, PMID 33593332, PMID 33831213, PMID 34611902, PMID 37316311, PMID 38348917, PMID 38491559, PMID 38663460, PMID 40736921, PMID 40803048

NIH funding

P50DA027840 (4), R34DA043751 (2), K01CA160670 (1), K23DA039294 (1), R01CA118035 (1), R01CA239309 (1), R01DA025598 (1), R21CA253600 (1)